Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

  • Filters activated: Cancer. Clear all to show 261 items.
1.

Exposure to antimuscarinic medications for treatment of overactive bladder and risk of lung cancer and colon cancer.

Löfling L, Sundström A, Kieler H, Bahmanyar S, Linder M.

Clin Epidemiol. 2019 Jan 23;11:133-143. doi: 10.2147/CLEP.S186842. eCollection 2019.

2.

Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom.

Margulis AV, Linder M, Arana A, Pottegård A, Berglind IA, Bui CL, Kristiansen NS, Bahmanyar S, McQuay LJ, Atsma WJ, Appenteng K, D'Silva M, Perez-Gutthann S, Hallas J.

PLoS One. 2018 Sep 27;13(9):e0204456. doi: 10.1371/journal.pone.0204456. eCollection 2018.

3.

Incidence of Common Cancers in Users of Antimuscarinic Medications for Overactive Bladder: A Danish Nationwide Cohort Study.

Hallas J, Margulis AV, Pottegård A, Kristiansen NS, Atsma WJ, Appenteng K, de Vogel S, Kaye JA, Perez-Gutthann S, Arana A.

Basic Clin Pharmacol Toxicol. 2018 Jun;122(6):612-619. doi: 10.1111/bcpt.12965. Epub 2018 Feb 22.

4.

Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias.

Kaye JA, Margulis AV, Fortuny J, McQuay LJ, Plana E, Bartsch JL, Bui CL, Perez-Gutthann S, Arana A.

Pharmacotherapy. 2017 Jun;37(6):673-683. doi: 10.1002/phar.1932. Epub 2017 May 29.

5.

Emerging therapies: what's new is old and what's old is new.

Barkin J, Folia C.

Can J Urol. 2012 Oct;19 Suppl 1:49-53. Review.

6.

Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review.

Kaplan SA, Roehrborn CG, Abrams P, Chapple CR, Bavendam T, Guan Z.

Int J Clin Pract. 2011 Apr;65(4):487-507. doi: 10.1111/j.1742-1241.2010.02611.x. Epub 2011 Jan 7. Review.

PMID:
21210910
7.

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol. 2010 Jun;32(5):331-88. doi: 10.1358/mf.2010.32.5.1520420.

PMID:
20664824
8.

Thorough QT study of the effect of fesoterodine on cardiac repolarization.

Malhotra B, Wood N, Sachse R, Gandelman K.

Int J Clin Pharmacol Ther. 2010 May;48(5):309-18.

PMID:
20420787
9.

New Drugs2010, PART 1.

Hussar DA.

Nursing. 2010 Feb;40(2):36-45; quiz 45-7. doi: 10.1097/01.NURSE.0000367864.13317.2a. No abstract available.

PMID:
20083979
10.

Gateways to clinical trials.

Tomillero A, Moral MA.

Methods Find Exp Clin Pharmacol. 2008 Sep;30(7):543-88.

PMID:
18985183
11.

Gateways to clinical trials.

Bayes M, Rabasseda X, Prous JR.

Methods Find Exp Clin Pharmacol. 2006 Dec;28(10):719-40.

PMID:
17235418
12.

Gateways to clinical trials.

Bayes M, Rabasseda X, Prous JR.

Methods Find Exp Clin Pharmacol. 2006 Jul-Aug;28(6):379-412.

PMID:
16894408

Supplemental Content

Loading ...
Support Center